News
Transdermal Diagnostics raises £1.1 million in pre-seed round
Transdermal Diagnostics, a Bristol-based MedTech spin-out, has secured £1.1 million to develop the world’s first 100% needle-free platform for blood sugar monitoring.
Transdermal Diagnostics, a Bristol-based MedTech spin-out, has secured £1.1 million to develop the world’s first 100% needle-free platform for blood sugar monitoring.